Analysts think AEMD stock price could increase by 925%
Jul 31, 2024, 6:26 AM
5.25%
What does AEMD do
Aethlon Medical Inc, based in San Diego, develops the Hemopurifier, a device aimed at treating cancer and viral infections by removing tumor-derived exosomes and various glycosylated viruses. The device targets conditions like HIV, HCV, Ebola, and multiple cancer types, focusing on both metastatic cancer treatment and life-threatening viruses without approved therapies.
4 analysts think AEMD stock price will increase by 925.33%. The current median analyst target is $3.93 compared to a current stock price of $0.38. The lowest analysts target is $0.71 and the highest analyst target is $7.35.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
